ORLANDO – Was December just a bit of holiday indulgence for the generic industry, or were the end-of-year submissions the beginning of a trend that could fuel friction between industry and FDA?
FDA's Office of Generic Drugs Director Kathleen Uhl didn't address the question at the Generic Pharmaceutical Association's annual meeting on Feb
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?